Australia's community-led response to HIV has put an internationally remarkable goal within reach, but new challenges are ...

For the past four decades, oral antiretroviral therapy for HIV has required daily doses. Long-acting injectable cabotegravir ...

Researchers have found a striking new way to potentially eliminate HIV soon after infection using a one-time combination of three therapies. In newborn nonhuman primates treated within three days of ...

International health organisations and experts say antiretroviral therapy and medication helps people living with HIV to live ...

The United Nations has set a goal for near universal HIV diagnosis and treatment for all by 2030. No country in Asia has hit ...

Gilead's twice-yearly shot reduced HIV infections by 96% in a second large study, the company said. The data sets the stage for likely FDA approval of lenacapavir for HIV prevention. Shares rose 3% in ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A new sequential immunization strategy shows strong promise for an HIV vaccine, a ...

ART iniitiation, managing comorbidities addressed for aging patients ...

A similar model of bringing testing into less engaged communities could potentially be implemented elsewhere with adequate funding, resources, and buy-in.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. NAKURU, KENYA - 2026/03/26: A healthcare worker fills a syringe with a dose of lenacapavir, ...

The height of the AIDS epidemic hit Cambodia in the late 90s. More than 180,000 people were infected. A full-on government effort to find at-risk populations and distribute medication has gotten the ...

In the early decades of the global response to HIV/AIDS, the focus was on saving lives. And rightly so: without antiretroviral treatment (ART), people lived less than a year, on average, from the time ...